Showing results (101-110 of 184) with videos related to
Sort By:
Pageof 19
Biorxiv : the Preprint Server for Biology|November 28, 2024
Free water elimination tractometry for aging brainsKelly Chang, Luke Burke, Nina LaPiana, et al.International Journal of Cardiology|February 11, 2014
Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyAnne Funke-Kaiser, Kristy Mann, David Colquhoun, et al.Lancet (London, England)|August 22, 2006
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control studyKoon K Teo, Stephanie Ounpuu, Steven Hawken, et al.Journal of Vascular Surgery. Venous and Lymphatic Disorders|August 16, 2020
Deep vein thrombosis protocol optimization to minimize healthcare worker exposure in coronavirus disease-2019Anahita Dua, Vikas Thondapu, Rachel Rosovsky, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2012
Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational studyGraeme J Hankey, Neil E Anderson, Ru-Dee Ting, et al.Journal of Hypertension|December 11, 2002
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatinMalcolm J West, Harvey D White, R John Simes, et al.Infection Control and Hospital Epidemiology|February 3, 2016
Evaluation of a Novel Intervention to Reduce Unnecessary Urine Cultures in Intensive Care Units at a Tertiary Care Hospital in Maryland, 2011-2014Lauren Epstein, Jonathan R Edwards, Alison Laufer Halpin, et al.JAMA|June 16, 2005
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trialsShamir R Mehta, Christopher P Cannon, Keith A A Fox, et al.Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.Circulation. Cardiovascular Quality and Outcomes|July 18, 2023
Relationship Between In-Hospital Adverse Events and Hospital Performance on 30-Day All-cause Mortality and Readmission for Patients With Heart FailureYun Wang, Noel Eldridge, Mark L Metersky, et al.Pageof 19